11
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Company Profile: Hoechst: Analysis of patenting 1991–1994

Pages 1309-1318 | Published online: 03 Mar 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (17)

Mary Ellen Mogee & Richard G Kolar. (1998) Patent citation analysis of new chemical entities claimed as pharmaceuticals. Expert Opinion on Therapeutic Patents 8:3, pages 213-222.
Read now
Peter R Steele. (1996) Company Profile: Eisai: analysis of patenting 1993-1996. Expert Opinion on Therapeutic Patents 6:11, pages 1131-1138.
Read now
Peter Steele. (1996) Company Profile Sankyo: analysis of patenting 1993 – 1996. Expert Opinion on Therapeutic Patents 6:10, pages 955-965.
Read now
Peter Steele. (1996) Company Profile: Monsanto: Analysis of patenting 1993–1996. Expert Opinion on Therapeutic Patents 6:7, pages 611-617.
Read now
Peter Steele. (1996) Company Profile: Boehringer Ingelheim: Analysis of patenting 1992 - 1995. Expert Opinion on Therapeutic Patents 6:1, pages 1-9.
Read now
Peter Steele. (1995) Company Profile Sanofi: Analysis of patenting 1992–1995. Expert Opinion on Therapeutic Patents 5:12, pages 1259-1267.
Read now
Peter Steele. (1995) Company Profile Part Two Upjohn: Analysis of Patenting 1992-1995. Expert Opinion on Therapeutic Patents 5:11, pages 1155-1161.
Read now
Peter Steele. (1995) Company Profile: Part One Pharmacia: Analysis of Patenting 1992-1995. Expert Opinion on Therapeutic Patents 5:11, pages 1147-1154.
Read now
Peter Steele. (1995) Company Profile: Warner-Lambert: analysis of patenting 1992 – 1995. Expert Opinion on Therapeutic Patents 5:10, pages 1015-1025.
Read now
Peter Steele. (1995) Company Profile Sandoz: Analysis of patenting 1991–1995. Expert Opinion on Therapeutic Patents 5:8, pages 735-745.
Read now
Peter Steele. (1995) Company Profile: Yamanouchi: analysis of patenting 1989-1995. Expert Opinion on Therapeutic Patents 5:7, pages 611-622.
Read now
Peter Steele. (1995) Company Profile: Bristol-Myers Squibb: analysis of patenting 1992–1995. Expert Opinion on Therapeutic Patents 5:6, pages 517-528.
Read now
Peter Steele. (1995) Company Profile Ciba-Geigy: analysis of patenting 1991 - 1995. Expert Opinion on Therapeutic Patents 5:5, pages 381-389.
Read now
Peter Steele. (1995) Company Profile Zeneca: Analysis of patenting 1991–1995. Expert Opinion on Therapeutic Patents 5:4, pages 277-285.
Read now
Peter Steele. (1995) Company Profile: Johnson & Johnson: analysis of patenting 1989–1995. Expert Opinion on Therapeutic Patents 5:3, pages 199-210.
Read now
Peter Steele. (1995) Company Profile: Wellcome: analysis of patenting 1989 – 1995. Expert Opinion on Therapeutic Patents 5:3, pages 191-198.
Read now
Peter Steele. (1995) Company Profile: Pfizer Inc: analysis of patenting 1989-1994. Expert Opinion on Therapeutic Patents 5:2, pages 99-110.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.